Several reports utilizing shRNA or siRNA-based targeting of EEF1A2 levels in cancerous cell lines have shown how depletion of EEF1A2 compromises the oncogenic potential of tumor cells [53]. This evidence concerns the gene EEF1A2 and neoplasm.